A robust gene signature for the prediction of early relapse in stage I–III colon cancer

Colon cancer patients experiencing early relapse consistently exhibited poor survival. The aim of our study was to develop an mRNA signature that can help to detect early relapse cases in stage I–III colon cancer. Public microarray datasets of stage I–III colon cancer samples were extracted from the...

Full description

Bibliographic Details
Main Authors: Weixing Dai, Yaqi Li, Shaobo Mo, Yang Feng, Long Zhang, Ye Xu, Qingguo Li, Guoxiang Cai
Format: Article
Language:English
Published: Wiley 2018-04-01
Series:Molecular Oncology
Subjects:
Online Access:https://doi.org/10.1002/1878-0261.12175